For research use only. Not for therapeutic Use.
VULM 993(CAT: I038216) is a pharmaceutical compound primarily investigated for its potential therapeutic effects in managing cardiovascular and metabolic disorders. While specific details about its mechanism of action and pharmacological targets may vary, it is often associated with studies on vascular health, lipid metabolism, or blood pressure regulation. VULM 993 serves as a valuable tool in research aimed at developing innovative treatments for conditions such as atherosclerosis, hypertension, and related metabolic syndromes. Further exploration of its properties may provide insights into its efficacy and potential clinical applications.
Catalog Number | I038216 |
CAS Number | 155506-70-0 |
Synonyms | VULM 993; VULM993; VULM-993 |
Molecular Formula | C25H30ClNO6 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 1,4-Dioxaspiro(4.4)non-2-ylmethyl ethyl 4-(3-chlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate |
InChI | InChI=1S/C25H30ClNO6/c1-4-30-23(28)20-15(2)27-16(3)21(22(20)17-8-7-9-18(26)12-17)24(29)31-13-19-14-32-25(33-19)10-5-6-11-25/h7-9,12,19,22,27H,4-6,10-11,13-14H2,1-3H3 |
InChIKey | GDMNURLVWVGYHR-UHFFFAOYSA-N |
SMILES | CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)Cl)C(=O)OCC3COC4(O3)CCCC4)C)C |